The TYR Gene
- NOTOC**
The TYR Gene
The TYR gene encodes tyrosinase, one of the central enzymes responsible for producing melanin in humans and other animals. Tyrosinase operates within specialized pigment-producing organelles called melanosomes and catalyzes early reactions in the biochemical pathway that produces eumelanin and pheomelanin. Because these pigments contribute to coloration of the skin, hair, and eyes, genetic variation affecting TYR can influence both ordinary differences in human pigmentation and inherited disorders characterized by greatly reduced pigmentation.
Research on TYR spans more than four decades of molecular genetics, biochemistry, cell biology, population genetics, ophthalmology, dermatology, evolutionary biology, cancer research, and clinical genetics. The gene became especially important after researchers discovered that mutations disrupting tyrosinase cause oculocutaneous albinism type 1 (OCA1). Hundreds of TYR variants have since been identified, ranging from variants that completely eliminate enzyme activity to common alleles that produce much subtler effects.
The study of TYR therefore illustrates an important principle of human genetics: variation within the same gene can contribute to severe Mendelian disease, mild clinical phenotypes, ordinary differences between individuals, and population-level evolutionary adaptation.
Tyrosinase and Melanin Production
Melanin is produced primarily by melanocytes, specialized cells located in the skin, hair follicles, and parts of the eye. Within melanocytes, pigment synthesis occurs inside melanosomes.
Tyrosinase occupies a central position in this process. It is a copper-containing enzyme that catalyzes the early oxidation reactions that begin melanogenesis. These reactions ultimately feed into pathways producing two major forms of pigment: eumelanin, generally associated with brown and black pigmentation, and pheomelanin, associated with yellow and reddish pigmentation.
Because tyrosinase acts near the beginning of melanin synthesis, loss of its activity can dramatically reduce pigment production. Conversely, changes that only modestly affect TYR expression or activity may produce much smaller differences in pigmentation.
The amount of functional tyrosinase in a melanocyte is determined by more than the DNA sequence of the enzyme itself. TYR must be correctly transcribed, translated, folded, modified, transported through the cell, supplied with copper, delivered to melanosomes, and maintained in a biochemical environment where it can function effectively.
This makes pigmentation the result of an interconnected cellular system rather than the action of one isolated gene.
Protein Structure, Folding, and Copper Binding
Tyrosinase contains a catalytic region built around copper ions. Specific amino acids, particularly histidine residues, help coordinate these copper atoms. Mutations that disturb the catalytic center can sharply reduce or eliminate the ability of the enzyme to carry out reactions required for melanin synthesis.
Other mutations cause disease without directly affecting the catalytic site. Tyrosinase is synthesized in the endoplasmic reticulum, where it must fold into the proper three-dimensional configuration. Cellular quality-control systems inspect the developing protein, and improperly folded molecules may be retained and eventually degraded.
Studies of OCA1-associated mutations have shown that endoplasmic-reticulum retention and protein misfolding are major mechanisms of TYR dysfunction. A protein may possess a potentially functional catalytic region yet never reach the melanosome because its folding or intracellular transport has been disrupted.
Glycosylation also contributes to tyrosinase maturation. Specific carbohydrate modifications help regulate protein folding, quality control, stability, and transport. Chaperone proteins such as calnexin participate in this process.
These findings expanded the understanding of genetic disease beyond the simple idea that mutations merely destroy an enzyme's active site. TYR mutations can interfere with multiple stages of protein production and cellular processing.
Transport to the Melanosome
After maturation, tyrosinase must reach the melanosome. Intracellular trafficking systems recognize targeting signals in the protein and route it through cellular compartments.
Adaptor complexes including AP-1 and AP-3 participate in this transport system. Disruption of these pathways can alter pigmentation even when TYR itself is genetically intact.
The activity of tyrosinase can also depend on conditions inside melanosomes. Factors such as organelle maturation and pH influence the stability and efficiency of melanogenic enzymes.
TYR therefore operates within a larger network of genes controlling melanosome formation, intracellular transport, ion balance, protein processing, and pigment chemistry. This helps explain why mutations in numerous different genes can produce clinically similar forms of albinism.
Regulation of TYR Expression
The amount of tyrosinase produced by melanocytes is tightly regulated.
One of the most important regulators is MITF, the microphthalmia-associated transcription factor. MITF helps control melanocyte development and activates several genes involved in pigmentation, including TYR.
Other transcription factors and regulatory proteins cooperate with MITF. Regulatory sequences surrounding the TYR gene help restrict high levels of expression primarily to pigment-producing cells.
The melanocortin signaling pathway also influences TYR. Signaling involving cyclic AMP can increase MITF activity and stimulate melanogenic gene expression. This pathway helps connect external and physiological signals with changes in pigmentation.
Ultraviolet radiation can activate signaling pathways that increase melanogenesis. Experimental research has identified several molecular mechanisms through which ultraviolet exposure and associated cellular signals can increase TYR expression.
Regulation also occurs after transcription. MicroRNAs and other regulatory mechanisms can alter the abundance of proteins involved in the melanogenic pathway.
Consequently, variation affecting regulatory DNA may influence pigmentation even when the protein-coding portion of TYR remains unchanged.
TYR and Oculocutaneous Albinism Type 1
Pathogenic variants in TYR cause oculocutaneous albinism type 1. OCA1 is generally inherited in an autosomal recessive pattern, meaning affected individuals typically inherit functionally important TYR variants from both parents.
The clinical phenotype can vary greatly.
In severe forms, tyrosinase activity is nearly or completely absent and very little melanin is produced. Historically this phenotype has been called OCA1A.
Other individuals retain partial tyrosinase activity and may gradually develop pigmentation in their skin, hair, or eyes. These residual-activity phenotypes have often been described as OCA1B.
Research has identified an extensive range of disease-associated TYR variants, including:
- missense variants that change individual amino acids;
- nonsense variants that introduce premature termination codons;
- frameshift variants;
- insertions and deletions;
- splice-altering variants;
- deep-intronic variants;
- regulatory variants; and
- larger genomic deletions involving TYR.
This extraordinary diversity means that two people diagnosed with OCA1 may carry completely different molecular changes.
Genotype and Phenotype Are Not Always Simple
Early models of recessive genetic disease often assumed that two clearly pathogenic mutations would explain an affected individual's phenotype. TYR research has revealed a more complicated picture.
Some variants almost completely eliminate tyrosinase function, while others preserve substantial residual activity. Different combinations can therefore produce different degrees of pigmentation and visual impairment.
Common or relatively mild variants can be especially difficult to interpret. One extensively studied example is R402Q. Research has shown that this variant can produce a temperature-sensitive form of tyrosinase, but its clinical significance depends strongly on genetic context.
R402Q by itself should not automatically be interpreted as a fully penetrant disease-causing mutation. Its effects may depend on additional TYR variants, regulatory alleles, haplotypes, or other genetic factors.
Complex genotypes involving more than two relevant alleles have also been reported.
These findings illustrate why modern clinical genetics increasingly combines population frequency data, family segregation, computational predictions, biochemical experiments, RNA studies, and functional assays when evaluating TYR variants.
Modern Variant Interpretation
Large genetic databases now contain hundreds of reported TYR variants. Resources such as ClinVar, ClinVar Miner, and the Leiden Open Variation Database allow researchers and clinicians to compare previously reported variants, clinical classifications, molecular consequences, and patient observations.
A major challenge is the interpretation of variants of uncertain significance.
Sequence information alone may not reveal whether a missense or noncoding variant meaningfully reduces gene function. Functional experiments can therefore be important.
Recent high-throughput approaches make it possible to test many TYR variants simultaneously. Such assays can measure how individual sequence changes affect protein activity and provide evidence supporting the reclassification of previously uncertain variants.
RNA and minigene experiments have also become particularly useful for variants suspected of altering splicing. Deep-intronic variants may create abnormal splice sites or pseudoexons even though they lie far from conventional protein-coding regions.
These discoveries show that routine exon sequencing may not detect every molecular cause of OCA1.
Eye Development and Visual Effects
The consequences of reduced melanin extend beyond visible pigmentation.
Albinism commonly affects development of the visual system. Associated findings can include reduced visual acuity, photophobia, abnormal retinal development, and foveal hypoplasia, in which the central region of the retina does not develop its typical specialized structure.
The relationship between pigmentation and visual development demonstrates that melanin has biological roles during development in addition to determining visible coloration.
Some individuals with pigmentation-pathway variants can present with prominent ocular abnormalities even when changes in skin or hair pigmentation are comparatively subtle.
For this reason, clinical assessment of suspected albinism often combines dermatologic examination, ophthalmologic evaluation, family history, and molecular genetic testing.
Population Differences in TYR Variants
TYR variation differs substantially among human populations.
Studies from China, Japan, Korea, India, Pakistan, Iran, Russia, Mali, Egypt, Europe, Brazil, and other regions have identified different combinations of recurrent and population-specific variants.
Founder effects can cause particular pathogenic alleles to become relatively common within specific communities. Studies in parts of India, for example, have demonstrated how founder mutations can influence the local prevalence of OCA1.
Consanguinity can also increase the probability that individuals inherit two copies of the same rare recessive allele. Genetic studies of consanguineous families have therefore contributed greatly to the discovery of new albinism variants.
These patterns are important for genetic diagnosis. A variant that is common in one ancestry group may be rare in another, and assumptions derived from one population do not necessarily transfer directly to another.
Greater geographic diversity in genomic research is therefore important for accurate clinical interpretation.
TYR and Normal Human Pigmentation
TYR is not only an albinism gene.
Common genetic variation in and around TYR contributes to ordinary differences in pigmentation among people. Association studies have connected TYR variants with aspects of skin, eye, and hair color.
Normal pigmentation is highly polygenic. TYR operates alongside genes including MC1R, OCA2, HERC2, SLC24A5, SLC45A2, TYRP1, and many others.
Most common pigmentation alleles do not determine color by themselves. Instead, numerous genetic variants each contribute part of the overall phenotype.
Environmental factors, especially ultraviolet exposure, interact with this genetic background.
This continuum from ordinary variation to disease demonstrates that the distinction between a "pigmentation gene" and an "albinism gene" is artificial. The same biological pathway underlies both.
Human Evolution and Natural Selection
Pigmentation has been an important target of human evolution.
As human populations migrated into environments with different levels of ultraviolet radiation, natural selection acted on multiple genes involved in pigmentation. TYR is among the loci studied in this evolutionary context.
Ancient-DNA research has shown that frequencies of pigmentation-associated alleles changed through time in European populations. These changes demonstrate that present-day pigmentation patterns did not simply appear when modern humans first entered particular regions; they continued evolving after populations settled there.
Studies of admixed populations also help researchers separate the effects of particular genetic variants from broader ancestry. Populations with combinations of African, European, Indigenous American, South Asian, or other ancestry provide valuable opportunities for studying pigmentation genetics.
An important finding from the broader literature is that similar visible pigmentation can evolve through different genetic pathways. Human populations therefore provide examples of convergent evolution, in which similar traits arise partly through different combinations of genetic changes.
TYR contributes to this broader evolutionary system rather than functioning as a single determinant of skin color.
TYR, Ultraviolet Radiation, and Skin Cancer
Pigmentation affects the interaction between human skin and ultraviolet radiation.
Inherited pigmentation characteristics can influence susceptibility to ultraviolet damage and therefore contribute indirectly to skin-cancer risk. Genetic association studies have investigated TYR variants in relation to melanoma and other pigmentation-associated cancer risks.
The relationship is complex because a genetic variant may influence risk through visible pigmentation, tanning response, melanocyte biology, or interactions with other genes and environmental exposure.
TYR is therefore part of a larger network linking pigmentation genetics, ultraviolet sensitivity, and melanoma susceptibility.
This does not mean that a particular TYR allele alone determines whether an individual will develop melanoma. Cancer risk is multifactorial and reflects genetic, environmental, behavioral, and biological influences.
TYR, Vitiligo, and Autoimmunity
TYR also occupies an unusual position at the intersection of pigmentation and immunity.
Vitiligo results from the loss of pigment-producing melanocytes through autoimmune processes. Because tyrosinase is strongly expressed in melanocytes, researchers have investigated whether it can become a target of immune recognition.
Early studies reported antibodies capable of recognizing tyrosinase in some people with vitiligo. Other investigations found weaker or conflicting evidence, demonstrating that the precise importance of TYR-directed antibodies has remained debated.
Genetic research provides another connection. Genome-wide association studies have identified TYR variation among loci associated with susceptibility to generalized vitiligo.
This creates an intriguing biological relationship: proteins necessary for melanocyte specialization and pigmentation can also supply antigens recognized by the immune system.
Tyrosinase and Melanoma Immunology
The same melanocyte-specific expression that makes tyrosinase relevant to vitiligo has made it an important molecule in melanoma immunology.
Melanoma cells often retain expression of pigmentation-associated proteins, including tyrosinase. Immune cells can recognize peptides derived from these proteins.
TYR consequently became one of the melanocyte differentiation antigens investigated as a target for experimental melanoma immunotherapies.
Research on melanoma and vitiligo has revealed an important biological overlap. An immune response capable of attacking melanoma cells may sometimes also recognize normal melanocytes, potentially producing depigmentation.
Tyrosinase therefore provides a molecular link between pigment-cell biology, autoimmunity, and antitumor immunity.
Forensic DNA Phenotyping
Common TYR variants are also used in forensic DNA phenotyping.
Traditional forensic DNA analysis is primarily designed to determine whether biological samples match particular individuals. Phenotyping instead attempts to estimate externally visible characteristics from DNA.
Pigmentation-prediction systems combine variants from several genes. TYR markers appear alongside variants in genes such as HERC2, OCA2, MC1R, SLC24A5, and SLC45A2 in models designed to estimate probabilities of eye, hair, and skin coloration.
Systems such as HIrisPlex and related approaches demonstrate the predictive value of combining many pigmentation-associated markers.
However, prediction performance can differ across populations because allele frequencies, ancestry, and genetic interactions vary. Large studies of admixed populations emphasize the importance of validating prediction systems in diverse groups rather than assuming that models developed in one population will perform equally well everywhere.
Animal Models and Comparative Genetics
TYR is evolutionarily conserved across many vertebrates, and mutations in the gene have produced recognizable pigmentation phenotypes in numerous animal species.
Laboratory mice have been particularly important. Different Tyr alleles produce pigmentation ranging from relatively mild changes to complete albinism, allowing researchers to investigate pigment biology experimentally.
TYR mutations have also been associated with albinism or unusual coloration in animals including cats, ferrets, mink, and other species.
Siamese and Burmese cat coloration provides an especially striking example of temperature-sensitive tyrosinase activity. Mutations alter enzyme function according to tissue temperature, resulting in darker pigmentation in cooler regions of the body.
Comparative studies demonstrate that the fundamental role of tyrosinase in pigmentation arose long before modern humans and is deeply conserved across mammals and other vertebrates.
Emerging Treatments and Gene Therapy
Historically, treatment of albinism has concentrated on managing its consequences rather than correcting its molecular cause. Clinical care includes visual support, protection from ultraviolet radiation, ophthalmologic monitoring, and dermatologic care.
Advances in molecular medicine have begun to raise the possibility of treatments aimed at restoring pigmentation-pathway function.
Experimental studies have investigated gene transfer, pharmacologic approaches, and genome-editing strategies.
A particularly important direction is gene therapy for ocular manifestations of OCA1. Experimental work has used viral vectors to deliver functional human TYR to retinal pigment epithelium in animal models. Restoration of tyrosinase expression and melanin production provides evidence that at least some consequences of TYR deficiency may eventually become targets for molecular treatment.
Other experimental approaches attempt to increase residual enzyme activity rather than replace the gene completely.
These strategies remain an area of research, and experimental success should not be confused with established clinical treatment. Nevertheless, they demonstrate how decades of basic research on TYR structure, regulation, cellular trafficking, and disease genetics are beginning to inform therapeutic development.
Broader Importance of TYR Research
Few pigmentation genes illustrate the connection between molecular biology, medicine, and human evolution as clearly as TYR.
Research on the gene has contributed to understanding:
- how melanocytes manufacture pigment;
- how copper-containing enzymes function;
- how proteins fold and move through cells;
- how mutations produce inherited disease;
- how regulatory variation modifies gene expression;
- how pigmentation contributes to visual development;
- how founder effects and ancestry shape genetic disorders;
- how ordinary pigmentation differences arise;
- how natural selection alters human populations;
- how melanocyte proteins become autoimmune or tumor antigens;
- how DNA can be used to estimate visible pigmentation traits; and
- how molecular therapies might eventually correct inherited pigment disorders.
The TYR story also demonstrates why genes should not be viewed as having a single effect. Depending on the variant and its genetic context, changes affecting TYR can cause profound congenital albinism, mild hypopigmentation, subtle differences in eye or skin color, altered disease susceptibility, or no recognizable clinical abnormality at all.
Conclusion
The TYR gene is a central component of the biological system that produces human pigmentation. It encodes tyrosinase, a copper-dependent enzyme whose activity is required for efficient melanin synthesis. Severe disruption of TYR causes oculocutaneous albinism type 1, while milder and common variants contribute to a much broader spectrum of pigmentation.
Decades of research have shown that TYR function depends not only on the enzyme's catalytic sequence but also on transcriptional regulation, protein folding, glycosylation, copper binding, intracellular trafficking, melanosomal conditions, and interactions with other pigmentation genes.
The enormous variety of TYR alleles also demonstrates the complexity of genotype-phenotype relationships. Some mutations cause almost complete loss of pigmentation, while hypomorphic and regulatory variants can have subtler effects whose significance depends on other alleles, haplotypes, ancestry, and cellular context.
Beyond albinism, TYR research connects pigmentation with visual development, human evolution, ultraviolet biology, melanoma susceptibility, vitiligo, tumor immunology, forensic genetics, and comparative animal biology.
New functional assays, increasingly diverse population studies, improved sequencing methods, and experimental gene therapies continue to expand the understanding of this gene. What began as an investigation into the molecular cause of albinism has become a broad window into how genetic variation produces both human biological diversity and disease.
- TOC**
The TYR Gene
Gene, Clinical, and Variant Resources
TYR Tyrosinase
| National Center for Biotechnology Information | NCBI Gene | 2026
TYR encodes tyrosinase, a copper-containing enzyme essential to melanin biosynthesis. The enzyme catalyzes the initial oxidation of tyrosine and subsequent reactions leading to eumelanin and pheomelanin production. Pathogenic variants cause oculocutaneous albinism type 1.
TYR Gene Homepage
| William Oetting and contributors | Leiden Open Variation Database | 2026
The LOVD TYR database catalogs hundreds of reported sequence variants and associated patient observations. It provides a valuable reference for comparing pathogenic, likely pathogenic, uncertain, and other variants identified during genetic testing.
All Variants in the TYR Gene
| LOVD Contributors | Leiden Open Variation Database | 2026
This searchable collection provides detailed records of TYR sequence variants reported in clinical and research settings, including substitutions, insertions, deletions, splice alterations, protein consequences, and reported disease associations.
Variants in the TYR Gene
| ClinVar Miner | University of Utah | 2026
This resource organizes hundreds of TYR variants submitted to ClinVar, allowing comparison of genomic position, clinical significance, allele frequency, molecular consequence, and conflicting interpretations.
Pathogenic Variants in TYR
| ClinVar Miner | University of Utah | 2026
This database view isolates TYR variants classified as pathogenic, providing a useful starting point for studying the molecular diversity of OCA1 and recurrent disease-associated mutations.
Melanin Biosynthesis
| Steven Jupe et al. | Reactome | 2025
This pathway resource maps TYR into the biochemical network responsible for melanin production. Tyrosinase catalyzes oxidation reactions that initiate melanogenesis and help determine the amount and type of pigment produced by melanocytes.
Oculocutaneous Albinism
| National Library of Medicine | MedlinePlus Genetics | 2024
This overview explains the major genetic forms of oculocutaneous albinism, including TYR-associated OCA1, and describes how reduced melanin affects pigmentation, vision, photophobia, foveal development, and susceptibility to ultraviolet damage.
TYR c.832C>T (p.Arg278Ter)
| ClinVar Contributors | NCBI ClinVar | 2024
This ClinVar record documents a nonsense TYR variant that introduces a premature termination codon. Such loss-of-function variants illustrate how disruption of tyrosinase production can produce severe OCA1 phenotypes.
Oculocutaneous Albinism and Ocular Albinism Overview
| Mervyn G. Thomas et al. | GeneReviews | 2023
This comprehensive clinical review describes the genetics, diagnosis, ophthalmic manifestations, inheritance, testing, and management of albinism. TYR-associated OCA1 is one of the major forms of nonsyndromic oculocutaneous albinism.
Nonsyndromic Oculocutaneous Albinism and Ocular Albinism by Gene
| Thomas, Zippin, and Brooks | GeneReviews | 2023
This GeneReviews table compares genes responsible for nonsyndromic albinism. TYR is responsible for OCA1 and represents one of the most common molecular causes of oculocutaneous albinism in populations of European ancestry.
Human OCA1 Genetics, Variants, and Molecular Diagnosis
Oculocutaneous Albinism Variants in 28 Consanguineous Families and a Deep-Intronic TYR Variant
| Muhammad Farooq et al. | European Journal of Human Genetics | 2026
Analysis of 28 consanguineous families identified disease-causing albinism variants and demonstrated a deep-intronic TYR mutation that creates abnormal splicing. Functional minigene experiments showed how the variant generates a pseudoexon and disrupts normal TYR transcripts.
Molecular Characterization of Oculocutaneous Albinism in Consanguineous Pakistani Families
| Haiba Kaul et al. | Biochemical Genetics | 2026
This study investigates the molecular causes of albinism in Pakistani families with high levels of consanguinity, identifying TYR and other pigmentation-gene variants and expanding knowledge of population-specific albinism genetics.
Genetic Features of Albinism: A Comprehensive Analysis in the Russian Population
| Multiple authors | Pigment Cell & Melanoma Research | 2026
Researchers characterized the genetic spectrum of albinism in a Russian cohort and examined TYR alongside other albinism genes, helping define recurrent variants and population-specific contributions to disease.
Population- and Haplotype-Dependent Variation Around TYR rs1126809
| Árpád Ármin Balogh, Márta Széll, and Nikoletta Nagy | JID Innovations | 2026
This study explores population differences surrounding the common TYR R402Q variant rs1126809. It emphasizes that the biological and clinical interpretation of a TYR allele can depend strongly on the surrounding haplotype and ancestry.
Multiplexed Assays of Variant Effect and Reclassification of TYR Variants
| Shushu Lv, Zhenhua Hao, Wei Li, and Aihua Wei | Journal of Investigative Dermatology | 2025
High-throughput functional assays were used to evaluate TYR variants of uncertain significance. Functional evidence enabled many variants to be reclassified and substantially improved the molecular diagnosis of patients whose conventional genetic testing had been inconclusive.
Genetic Diagnosis of OCA1A: A Novel TYR Variant
| Multiple authors | PubMed-indexed study | 2025
Genetic analysis identified a novel TYR variant, c.143A>C (p.Gln48Pro), in a family affected by OCA1A. The study adds another potentially pathogenic allele to the diverse mutational spectrum of TYR-associated albinism.
TYR Mutation in a Chinese Population With Oculocutaneous Albinism
| Chonglin Chen et al. | Experimental Eye Research | 2024
A Chinese OCA cohort was genetically and clinically characterized, identifying TYR mutations in a substantial proportion of patients. The study also links genetic findings with severe ocular manifestations such as foveal hypoplasia and impaired visual acuity.
Biallelic TYR and TKFC Variants in Egyptian Patients With OCA1
| Engy A. Ashaat et al. | BMC Genomics | 2024
Genomic analysis of Egyptian patients identified biallelic TYR variants while also investigating additional genetic findings. The work illustrates the complexity that can emerge when pigmentation disorders involve variants at more than one locus.
Genotypic Spectrum of Albinism in Mali
| Multiple authors | Pigment Cell & Melanoma Research | 2024
This study investigates albinism genetics in Mali, expanding molecular data from an African population that has historically been underrepresented in genomic studies of pigmentation disorders.
Identifying Genetic Defects in OCA Patients of West Bengal
| Multiple authors | PubMed-indexed study | 2024
Researchers examined the molecular causes of oculocutaneous albinism in patients from eastern India. TYR mutations form an important component of the regional genetic architecture of OCA.
Functional Characterization of Splice Variants in the Diagnosis of Albinism
| Multiple authors | PubMed-indexed study | 2024
This study uses functional analysis to determine whether suspected splice-altering variants disrupt normal albinism-gene transcripts. The work demonstrates why RNA and experimental evidence are often necessary to interpret noncanonical TYR variants.
Common Variants in TYR With Unclear Pathogenicity in Russian Patients
| Multiple authors | PubMed-indexed study | 2024
Researchers analyze common TYR alleles whose clinical significance is difficult to interpret. The study highlights the distinction between rare severe mutations and relatively common hypomorphic alleles that can modify pigmentation or contribute to disease in combination.
Genotype-Phenotype Correlation Model for TYR-Associated Albinism
| Multiple authors | Diagnostics | 2024
This work develops a model linking combinations of TYR variants with clinical severity. Genotype-phenotype models may improve prediction of residual tyrosinase activity, pigmentation, and visual outcomes in OCA1.
Compound Heterozygous TYR Variants in a Northern Chinese Family
| Multiple authors | PubMed-indexed study | 2023
Genetic investigation of an affected Chinese family identified compound heterozygous TYR variants. Family segregation analysis illustrates the recessive inheritance characteristic of most TYR-associated OCA1.
Contribution of Common Regulatory and Protein-Coding TYR Variants to Albinism
| Multiple authors | PubMed-indexed genetics study | 2022
This study shows that albinism risk can arise from combinations of regulatory and hypomorphic TYR alleles rather than only rare severe mutations. A promoter variant modifies the penetrance of the common R402Q allele.
Two Novel Noncoding TYR Variants Associated With Albinism
| Multiple authors | PubMed-indexed genetics study | 2022
This study identifies and characterizes noncoding TYR variants associated with albinism, showing that pathogenic changes outside protein-coding exons can affect gene regulation or RNA processing and escape routine diagnostic analysis.
Genotype-Phenotype Associations in Danish Patients With Albinism
| Multiple authors | PubMed-indexed clinical genetics study | 2021
Danish patients with genetically confirmed albinism were evaluated to determine how specific genotypes correspond with pigmentation and ocular characteristics. TYR genotypes contributed to substantial variation in clinical severity.
Study on a TYR Gene Variant From a Pedigree With Oculocutaneous Albinism
| Yingzhen Zhang et al. | Chinese Journal of Medical Genetics | 2021
Family-based genetic analysis identified a TYR variant responsible for recessively inherited albinism and demonstrated the continuing usefulness of pedigree analysis for interpreting candidate pathogenic alleles.
Genetic Analysis and Prenatal Diagnosis of 20 Chinese Families With OCA
| Multiple authors | Journal of Clinical Laboratory Analysis | 2021
Molecular testing of Chinese families identified pathogenic variants responsible for OCA and was used to support prenatal diagnosis. TYR represented an important disease gene among the affected families.
Mutation Analysis of 63 Northwest Chinese Probands With Oculocutaneous Albinism
| Multiple authors | PubMed-indexed study | 2020
Researchers characterized albinism-associated mutations in a large northwest Chinese cohort, defining recurrent and uncommon variants and improving understanding of the regional TYR mutation spectrum.
Non-Syndromic Oculocutaneous Albinism: A Brazilian Pediatric Cohort
| Multiple authors | PubMed-indexed clinical study | 2020
Brazilian children with nonsyndromic OCA were clinically and molecularly evaluated. The study illustrates the genetic heterogeneity of albinism in an admixed population and the role of TYR among several causative genes.
Mapping the TYR Gene in Eastern Indian Patients
| Multiple authors | PubMed-indexed genetics study | 2020
Researchers analyzed TYR mutations among patients from eastern India, a region in which founder effects and recurrent variants have previously been reported to influence the prevalence of OCA1.
Current Landscape of Oculocutaneous Albinism in Japan
| Multiple authors | PubMed-indexed review | 2020
This review summarizes the genetic and clinical spectrum of albinism in Japan. TYR is among the principal genes involved, with population-specific variants contributing to different OCA subtypes.
Novel TYR and SLC45A2 Mutations in Pakistani Families
| Multiple authors | Frontiers in Genetics | 2020
Researchers identified a novel TYR p.Cys276Arg variant and a recurrent p.Arg278Ter allele in Pakistani families. Structural modeling suggested that disruption of a cysteine bridge could destabilize the TYR protein.
Tyrosinase Gene Sequencing in Pakistani Families
| Multiple authors | PubMed-indexed genetics study | 2019
Sequencing of TYR in Pakistani families affected by albinism identified pathogenic alleles and demonstrates how consanguinity can increase the frequency of homozygous recessive mutations within families.
The Genetics of Human Skin and Hair Pigmentation
| Multiple authors | Annual Review of Genomics and Human Genetics | 2019
This major review discusses genetic pathways controlling pigmentation, including TYR and interacting melanogenesis genes. It connects Mendelian pigmentation disorders with common variation responsible for normal differences in skin and hair color.
Genetic Studies of Consanguineous Pakistani Families With Oculocutaneous Albinism
| Multiple authors | PubMed-indexed genetics study | 2019
Family-based sequencing identified mutations responsible for albinism in Pakistani pedigrees. Such studies have revealed both recurrent and novel TYR variants in populations with elevated consanguinity.
Mild Oculocutaneous Albinism Type 1 Associated With TYR R402Q
| Multiple authors | British Journal of Ophthalmology | 2019
This report examines individuals with mild albinism involving the common temperature-sensitive TYR R402Q variant. It contributes to debate over when common hypomorphic TYR alleles become clinically important in combination with other variants.
Novel TYR Splice Variant in an OCA Pedigree
| Multiple authors | Chinese Journal of Medical Genetics | 2019
Next-generation sequencing identified a previously unreported TYR intronic insertion near a splice junction in one pedigree, expanding the range of mutation classes relevant to OCA molecular diagnosis.
Identification of TYR Mutations in Chinese OCA Patients
| Multiple authors | Molecular Medicine Reports | 2018
Sequencing of nonsyndromic OCA patients identified twelve TYR variants, including novel p.W400G and p.Q273H missense changes, expanding the known mutation spectrum.
Identification of a Functionally Significant Tri-Allelic TYR Genotype
| Multiple authors | PubMed-indexed genetics study | 2017
Researchers describe a complex TYR genotype in which multiple alleles together influence phenotype. The work demonstrates that OCA1 inheritance can be more complicated than a simple model involving two fully penetrant mutations.
Identification of a Missense TYR Mutation in a Chinese Family
| Qian Lu et al. | Molecular Medicine Reports | 2017
Researchers identified a missense mutation in TYR segregating with oculocutaneous albinism in a Chinese pedigree and evaluated its likely effect on tyrosinase structure and function.
Functional Assessment of Tyrosinase Variants in Albinism
| Multiple authors | PubMed-indexed functional genetics study | 2016
Experimental assays were used to distinguish damaging TYR mutations from variants with residual or near-normal activity. Functional testing is particularly important for interpreting missense variants whose consequences cannot reliably be predicted from sequence alone.
Clinical Evaluation and Molecular Screening of a Large Series of Albino Patients
| Multiple authors | Journal of Human Genetics | 2016
A large clinical series was screened for mutations in albinism genes. The study documents extensive genetic heterogeneity while confirming TYR as one of the major contributors to nonsyndromic albinism.
Sequence Analysis of TYR in Ocular and Oculocutaneous Albinism Patients: Three Novel Mutations
| Multiple authors | PubMed-indexed genetics study | 2015
Sequencing identified previously unreported TYR mutations in patients with ocular or oculocutaneous manifestations, broadening the known allelic spectrum and emphasizing phenotypic overlap among pigmentation disorders.
Mutational Spectrum of TYR and SLC45A2 in Pakistani Families
| Multiple authors | PubMed-indexed genetics study | 2015
Researchers studied Pakistani families with albinism and identified disease-associated variants in TYR and SLC45A2. The study helps characterize the relative contribution of major OCA genes within this population.
Pathogenic TYR Frameshift Identified by Deep Sequencing
| Multiple authors | Chinese Journal of Medical Genetics | 2015
Genetic screening identified a TYR c.925_926insC frameshift mutation predicted to truncate the enzyme. Additional known pathogenic alleles were detected in partners undergoing carrier analysis.
Two Novel TYR Mutations With Pathogenic Impact on OCA1
| Vadieh Ghodsinejad Kalahroudi et al. | PLOS ONE | 2014
Two previously unreported TYR mutations were characterized as causes of OCA1. Molecular modeling and functional interpretation helped explain how the substitutions interfere with normal tyrosinase activity.
A Comprehensive Study of OCA1 Reveals Three New TYR Alleles
| Multiple authors | European Journal of Dermatology | 2014
Genetic analysis of OCA1 patients identified three additional TYR alleles and expanded the catalog of mutations responsible for reduced or absent tyrosinase activity.
Mutational Analysis of Oculocutaneous Albinism: A Compact Review
| Balu Kamaraj and Rituraj Purohit | BioMed Research International | 2014
This review summarizes mutations in major OCA genes and discusses their structural and functional consequences. TYR receives particular attention because OCA1 was the first molecularly characterized form of albinism.
Novel p.Ile198Thr Mutation in TYR in a Pakistani Family
| Multiple authors | PubMed-indexed genetics study | 2014
Family analysis identified a novel TYR missense mutation associated with oculocutaneous albinism. The finding adds to the extensive allelic heterogeneity observed in Pakistani families.
DNA Variations in Oculocutaneous Albinism
| Dimitre R. Simeonov et al. | Human Mutation | 2013
This broad molecular study investigates sequence variation across genes responsible for albinism and demonstrates the large number of pathogenic alleles involved. TYR remains one of the principal genes identified in affected patients.
Mutational Analysis of TYR and Structural Consequences in OCA1A
| Balu Kamaraj and Rituraj Purohit | Gene | 2013
The authors analyze TYR mutations associated with severe OCA1A and use structural approaches to predict how amino-acid substitutions destabilize tyrosinase or interfere with its catalytic function.
Molecular Genetic Studies of OCA Phenotype in a Pakistani Population
| Multiple authors | PubMed-indexed genetics study | 2012
This study investigates mutations underlying albinism in Pakistani families, contributing additional TYR alleles and illustrating the extensive genetic heterogeneity of pigmentation disorders.
Mutation Spectrum of TYR and SLC45A2 in Korean OCA Patients
| Jung Min Ko et al. | Molecular Medicine Reports | 2012
Eight of twelve Korean patients were molecularly diagnosed with OCA1. Several recurrent TYR mutations overlapped with variants previously observed in neighboring East Asian populations.
Molecular Analysis of Korean Patients With Oculocutaneous Albinism
| Multiple authors | PubMed-indexed clinical genetics study | 2011
Korean patients with OCA were screened for pathogenic variants. The results help define the mutation spectrum of TYR and other albinism genes in East Asian populations.
Novel TYR p.I151S Mutation in a Chinese OCA1 Family
| Yu-Ying Lin et al. | Chinese Medical Journal | 2011
Sequencing of a Chinese pedigree identified a homozygous p.I151S missense mutation in TYR associated with OCA1. The allele was absent from unaffected controls.
TYR Mutations in Chinese Patients With OCA1
| Jing Liu et al. | Clinical & Experimental Ophthalmology | 2010
Molecular testing of Chinese OCA1 patients revealed multiple TYR mutations, adding population-specific alleles to the growing catalog of pathogenic variants and supporting genetic confirmation of clinical diagnoses.
Spectrum of Candidate Gene Mutations in Indian Albinism
| Multiple authors | Molecular Vision | 2010
Indian patients with albinism were analyzed for mutations in pigmentation genes. The results show considerable allelic diversity and reinforce the importance of TYR in OCA1 within South Asian populations.
Genetic Analysis of OCA1A in an Iranian Family
| H. Pour-Jafari, A. Zamanian, and B. Pour-Jafari | Iranian Journal of Public Health | 2010
Genetic investigation of an Iranian pedigree identified TYR mutations underlying OCA1A and illustrates the use of family segregation analysis in recessive pigmentation disorders.
The R402Q Tyrosinase Variant Does Not Cause Autosomal Recessive Ocular Albinism by Itself
| William S. Oetting et al. | American Journal of Medical Genetics Part A | 2009
This study cautions against treating the common TYR R402Q allele as a fully penetrant pathogenic mutation on its own. Later research has shown that its impact can depend on additional TYR alleles and regulatory haplotypes.
Birth Prevalence and Mutation Spectrum in Danish Patients With Recessive Albinism
| Multiple authors | Investigative Ophthalmology & Visual Science | 2009
This Danish study estimates albinism prevalence and catalogs disease-causing mutations, providing population-level evidence about the contribution of TYR and other recessive albinism genes.
OCA1 in Different Ethnic Groups of India Due to Founder Mutations
| Multiple authors | PubMed-indexed population genetics study | 2006
Analysis of Indian populations demonstrates how founder mutations can produce elevated frequencies of specific TYR alleles within particular communities, creating marked geographic and ethnic differences in OCA1 prevalence.
Higher Prevalence of OCA1 in Eastern India Due to a Founder TYR Mutation
| Multiple authors | PubMed-indexed genetics study | 2005
Researchers identified a recurrent TYR mutation underlying a high frequency of OCA1 in eastern India. The study provides a clear example of how founder effects shape the distribution of recessive disease alleles.
Identification of Novel TYR and TYRP1 Mutations in Oculocutaneous Albinism
| T. Forshew et al. | Clinical Genetics | 2005
Mutation screening identified previously undescribed changes in pigmentation genes, further demonstrating the extensive allelic heterogeneity underlying clinically similar forms of albinism.
Genetic Analysis of OCA1 in Indian Families: Two Novel Frameshift TYR Mutations
| Periasamy Sundaresan et al. | Molecular Vision | 2004
Researchers identified two frameshift TYR mutations in Indian families with OCA1. Frameshift variants commonly produce severe loss of tyrosinase function because they alter the downstream protein sequence or introduce premature termination.
Tyrosinase Gene Analysis in Japanese OCA Patients
| Multiple authors | Journal of Dermatological Science | 2004
Molecular analysis of Japanese patients identified TYR mutations responsible for OCA1 and helped establish population-specific mutation patterns in Japan.
Fifty-Three Novel DNA Variations Within the TYR Gene
| Multiple authors | Human Mutation | 2004
Analysis of 82 individuals with recessively inherited albinism revealed extensive TYR variation, including dozens of previously unreported mutations and polymorphisms and several patients carrying unusually complex combinations of variants.
A Novel TYR Mutation Causing OCA1
| Eriko Nakamura et al. | Journal of Dermatological Science | 2002
This report describes the TYR R239W missense mutation in a patient with tyrosinase-negative OCA1A and examines its relationship with severe loss of pigment production.
Mutation Analysis of the Tyrosinase Gene in Oculocutaneous Albinism
| Multiple authors | Human Mutation | 2001
This mutation survey examines TYR variants in patients with albinism and contributes to the expanding catalog showing that OCA1 can result from many different missense, nonsense, splice, insertion, and deletion mutations.
OCA1 With an 11q14 Deletion Involving TYR
| Isabelle Coupry et al. | Journal of Medical Genetics | 2001
A patient with OCA1 carried a deletion removing part of TYR on one chromosome and a separate pathogenic TYR mutation on the other, illustrating how structural chromosome changes can cause OCA1.
Mutations of Human TYR Associated With OCA1
| W. S. Oetting, J. P. Fryer, and R. A. King | Human Mutation | 1998
This work catalogs disease-associated TYR mutations and illustrates the exceptional allelic heterogeneity of OCA1. Different variants can eliminate enzyme activity entirely or permit residual pigmentation to develop over time.
Mutations of TYR in Various Ethnic Groups in Israel
| R. Gershoni-Baruch et al. | American Journal of Human Genetics | 1994
TYR mutations were examined in patients from multiple ethnic groups in Israel. The results demonstrate substantial population-specific variation in pathogenic alleles and the influence of ancestry and founder effects on OCA1.
Analysis of Tyrosinase Mutations Associated With OCA1
| W. S. Oetting et al. | Pigment Cell Research | 1994
Researchers analyzed TYR mutations in individuals with OCA1 and related individual genotypes to biochemical and clinical consequences, helping establish the molecular diversity underlying tyrosinase-positive and tyrosinase-negative phenotypes.
Human Oculocutaneous Albinism: From Clinical Observation to Molecular Biology
| Multiple authors | PubMed-indexed review | 1994
This historical review traces the transition from clinical classification of albinism to molecular characterization of pigmentation genes. Identification of TYR mutations transformed understanding of classical tyrosinase-negative albinism.
Prenatal Diagnosis of Oculocutaneous Albinism by Analysis of the Fetal TYR Gene
| Multiple authors | Journal of Investigative Dermatology | 1994
This early molecular diagnostic study demonstrates prenatal detection of OCA1 using TYR sequence information, showing how identification of familial pathogenic variants enabled DNA-based diagnosis before birth.
Mutations of TYR in Indo-Pakistani Patients With Type I Oculocutaneous Albinism
| Multiple authors | American Journal of Human Genetics | 1993
TYR mutations were characterized in Indo-Pakistani patients with OCA1. The study contributed early evidence that different populations possess distinctive collections of pathogenic tyrosinase alleles.
Molecular Basis of Type IA Tyrosinase-Negative Oculocutaneous Albinism
| Multiple authors | PubMed-indexed molecular genetics study | 1992
Molecular analysis of severe OCA1A helped demonstrate that mutations in TYR can abolish tyrosinase activity entirely, explaining the absence of significant melanin production characteristic of classical tyrosinase-negative albinism.
Non-Random Distribution of Missense Mutations Within Human TYR
| Multiple authors | PubMed-indexed molecular genetics study | 1991
Analysis of disease-associated missense mutations showed that damaging substitutions are concentrated in functionally important regions of tyrosinase, helping identify protein domains that are especially intolerant of amino-acid changes.
Three Frameshift Mutations of TYR in Type IA Oculocutaneous Albinism
| Multiple authors | PubMed-indexed genetics study | 1991
Three frameshift mutations were identified in patients with severe OCA1A. The variants alter the normal reading frame and provide direct molecular explanations for complete loss of functional tyrosinase.
TYR Mutations in Type IB Yellow Albinism
| Multiple authors | PubMed-indexed genetics study | 1991
This early investigation demonstrates that TYR mutations can cause a milder OCA1 phenotype in which some pigmentation develops. The findings helped establish the distinction between OCA1A and residual-activity OCA1B.
Detection of a Point Mutation in the Tyrosinase Gene of a Japanese Albino Patient
| Multiple authors | PubMed-indexed molecular genetics study | 1990
Researchers identified a specific TYR point mutation in a Japanese patient with albinism, among the early demonstrations that direct DNA sequencing could reveal the molecular basis of OCA1 in individual patients.
Molecular Basis of OCA: An Arg59Gln Substitution in Tyrosinase
| Multiple authors | PubMed-indexed molecular genetics study | 1990
This study describes an amino-acid substitution in human tyrosinase associated with albinism and helped establish the principle that single missense changes can be sufficient to disrupt pigmentation.
Clinical Albinism, Ophthalmology, and Epidemiology
Determining a Worldwide Prevalence of Oculocutaneous Albinism
| Multiple authors | Investigative Ophthalmology & Visual Science | 2023
This study estimates the global prevalence of oculocutaneous albinism. Although several genes cause OCA, TYR is one of the most important contributors and prevalence varies substantially among populations.
Genotypic and Phenotypic Spectrum of Foveal Hypoplasia
| Multiple authors | PubMed-indexed ophthalmic genetics study | 2022
This work examines genetic causes of foveal hypoplasia, a characteristic ocular feature of albinism. TYR-associated albinism demonstrates how impaired pigmentation during development can affect specialization of the central retina.
Expanding the Oculocutaneous Albinism Spectrum and Isolated Foveal Hypoplasia
| Multiple authors | PubMed-indexed ophthalmic genetics study | 2022
Genetic analysis broadens the recognized clinical spectrum associated with albinism genes and emphasizes that reduced pigmentation-pathway function can sometimes present predominantly through ocular developmental abnormalities.
TYR R402Q and S192Y Hypomorphic Alleles and Foveal Structure
| Multiple authors | Ophthalmology Science | 2022
Researchers examined whether common TYR hypomorphic alleles alter normal foveal pit or foveal avascular-zone morphology, exploring subtle ocular effects of pigmentation-associated variants outside classical albinism.
Molecular Characterization of 990 Index Patients With Albinism
| Multiple authors | PubMed-indexed large cohort study | 2018
Molecular testing of 990 index patients provided one of the largest genetic datasets on albinism. The study demonstrates extensive locus and allelic heterogeneity and documents the major contribution of TYR to nonsyndromic disease.
The Phenotypic Spectrum of Albinism
| Multiple authors | PubMed-indexed clinical review | 2018
This study describes the broad range of pigmentation and ocular findings associated with genetically defined albinism. TYR variants can produce phenotypes ranging from profound congenital hypopigmentation to comparatively subtle disease.
Lessons of a Day Hospital: Comprehensive Assessment of Patients With Albinism
| Multiple authors | PubMed-indexed clinical study | 2017
Comprehensive assessment of patients with albinism combines dermatologic, ophthalmologic, and genetic findings. The study illustrates the value of molecular testing, including TYR sequencing, for classifying clinically overlapping forms of albinism.
TYR and Ocular Diseases: Novel Thoughts on an Old Gene
| Multiple authors | PubMed-indexed review | 2007
This article considers the role of TYR beyond visible pigmentation and discusses how tyrosinase activity and melanin production influence development and function of the eye.
Oculocutaneous Albinism in Southern Africa: Population Structure, Health, and Genetic Care
| P. M. Lund | Annals of Human Biology | 2005
This review discusses the unusually high prevalence of albinism in parts of southern Africa, its health consequences, population genetics, and the importance of appropriate dermatologic, ophthalmic, and genetic services.
TYR Mutations and the OCA1 Phenotype
| Multiple authors | PubMed-indexed genotype-phenotype study | 2003
This study examines relationships between particular TYR mutations and clinical expression of OCA1, emphasizing the importance of residual enzyme activity in determining whether pigmentation remains absent or increases with age.
Tyrosinase Protein Structure, Catalysis, Folding, and Trafficking
Structural Characterization of Tyrosinases and an Update on Human Enzymes
| Luigi Di Costanzo | Methods in Enzymology | 2024
This review examines structural knowledge of tyrosinases, including the copper-containing catalytic center of human TYR. Structural studies help explain why mutations at particular residues interfere with enzyme folding, copper binding, or catalytic activity.
Catalytic Mechanism of Tyrosinases
| Multiple authors | Methods in Enzymology | 2024
This review examines the catalytic mechanism shared by tyrosinases across organisms. Human TYR contains a binuclear copper center coordinated by histidines that supports both monophenolase and diphenolase reactions during melanin synthesis.
pH Dependence of Tyrosinase and Melanosomal Proteins
| Mahesh Koirala et al. | International Journal of Molecular Sciences | 2021
Computational analysis shows that TYR stability and activity are strongly influenced by melanosomal pH. The neutralization of mature melanosomes creates conditions favorable for tyrosinase-mediated melanin synthesis.
Histidine Residues at the Copper-Binding Site in Human Tyrosinase
| Hyangsoon Noh et al. | Journal of Enzyme Inhibition and Medicinal Chemistry | 2020
Site-directed mutagenesis demonstrated that histidine residues coordinating the two copper ions are essential for tyrosinase activity. Mutations affecting the CuB site strongly reduced both tyrosine hydroxylation and DOPA oxidation.
Structure and Function of Human Tyrosinase and Tyrosinase-Related Proteins
This review examines the structure and function of human TYR and related melanogenic enzymes. Structural modeling helps explain how OCA1 mutations disrupt catalytic activity, copper coordination, protein stability, or substrate binding.
Large-Scale Recombinant Expression and Purification of Human Tyrosinase
| Multiple authors | Protein Expression and Purification | 2016
Researchers developed a system for producing large quantities of purified human tyrosinase suitable for structural studies. The work provides an experimental platform for studying TYR catalytic activity, OCA1 mutations, and potential tyrosinase inhibitors.
C-Terminus Glycans With Critical Functional Roles in Tyrosinase Maturation
| Multiple authors | Molecular Biology of the Cell | 2011
Researchers examined individual N-glycosylation sites in human tyrosinase and found that specific C-terminal glycans are particularly important for productive protein folding, ER quality control, and enzymatic activity.
Soluble Tyrosinase as an ER-Associated Degradation Substrate
| Costin I. Popescu et al. | Journal of Biological Chemistry | 2005
A truncated soluble form of TYR was used to investigate ER retention and degradation. The study found important roles for calreticulin and BiP/GRP78 in recognizing improperly matured tyrosinase.
Functions of AP-3 and AP-1 in Tyrosinase Sorting
| Multiple authors | Molecular Biology of the Cell | 2005
AP-3 and AP-1 were shown to mediate partly redundant routes transporting tyrosinase from endosomes toward melanosomes. These pathways help prevent TYR from becoming trapped within inappropriate endosomal compartments.
Phenylthiourea-Induced Tyrosinase Degradation After Golgi Maturation
| Multiple authors | Journal of Investigative Dermatology | 2005
Phenylthiourea, commonly used as a tyrosinase inhibitor, was found to promote selective degradation of mature tyrosinase after passage through the Golgi apparatus, revealing an additional post-Golgi quality-control pathway.
Carbohydrates as Sorting Determinants in ER-Associated Degradation of Tyrosinase
| Sherri Svedine et al. | Journal of Cell Science | 2004
N-linked glycans help ER quality-control systems distinguish properly folded tyrosinase from defective molecules. Changes in glycan processing influence whether mutant TYR is stabilized, aggregated, or directed toward proteasomal degradation.
Tyrosinase Maturation and Oligomerization Require a Melanocyte-Specific Factor
| Multiple authors | Journal of Biological Chemistry | 2003
Human TYR folded poorly in nonmelanocytic cellular environments but matured more effectively in melanocytes. The work indicates that melanocyte-specific proteins such as TYRP1 can facilitate proper tyrosinase maturation.
Identification of Active-Site Residues in Mammalian Tyrosinase
| Concepción Olivares, José C. García-Borrón, and Francisco Solano | Biochemistry | 2002
Biochemical experiments identify residues important to mammalian tyrosinase catalysis. These studies provide a mechanistic framework for understanding why mutations near the copper-binding catalytic center can severely reduce melanin production.
Sorting Failure and Degradation of Mutant Tyrosinases in OCA1
| Multiple authors | European Journal of Biochemistry | 2001
Mutant tyrosinases associated with OCA1 were retained by calnexin and rapidly degraded rather than transported normally to melanosomes. Even mutations distant from the active site can therefore cause disease through subtle folding abnormalities.
Tyrosinase Degradation Via Two Pathways During Reverse Translocation
| Multiple authors | Experimental Cell Research | 2001
Researchers characterized multiple pathways through which misfolded tyrosinase can be moved from the ER into the cytosol and degraded. The findings illuminate cellular quality-control mechanisms relevant to OCA1.
AP-3 Mediates Tyrosinase Trafficking in Human Melanocytes
| Multiple authors | Molecular Biology of the Cell | 2001
Studies of Hermansky-Pudlak syndrome melanocytes demonstrated that adaptor protein complex AP-3 is involved in transporting tyrosinase toward premelanosomes. TYR contains a cytoplasmic targeting signal recognized by this sorting machinery.
Intracellular Vesicular Trafficking of Tyrosinase Gene Family Proteins
| Multiple authors | Pigment Cell Research | 2000
This study examines how tyrosinase-family proteins move through the secretory pathway and are delivered to melanosomes. Correct intracellular trafficking is essential because melanin synthesis must occur within specialized pigment organelles.
Assembly and Intracellular Transport of Tyrosinase Gene Family Proteins
| Multiple authors | Pigment Cell Research | 2000
Researchers investigate the maturation, assembly, and transport of tyrosinase and related proteins. Mutations that impair folding or trafficking can reduce pigmentation even when the catalytic portion of the enzyme remains partly intact.
A Common Temperature-Sensitive Allelic Form of Human Tyrosinase
| Multiple authors | Journal of Biological Chemistry | 2000
The common R402Q variant was shown to be temperature sensitive. At normal physiological temperature the altered protein is retained in the endoplasmic reticulum, whereas at lower temperature more TYR reaches downstream cellular compartments.
Endoplasmic Reticulum Retention as a Common Defect in Tyrosinase-Negative Albinism
| Multiple authors | Proceedings of the National Academy of Sciences | 2000
Several OCA1-associated TYR variants were shown to remain trapped in the ER rather than reaching melanosomes. The work established protein misfolding and trafficking failure as major molecular mechanisms of TYR-associated albinism.
Tyrosinase Folding and Copper Loading In Vivo
| Multiple authors | Biochemical and Biophysical Research Communications | 1999
This study demonstrates the importance of calnexin and glucosidase-dependent quality control during TYR folding. Premature escape from the calnexin cycle can produce protein unable to bind copper and therefore unable to catalyze melanogenesis efficiently.
Promotion of Tyrosinase Folding by Calnexin
| Multiple authors | Journal of Biochemistry | 1999
Experiments in COS-7 cells showed that the ER chaperone calnexin promotes maturation of human tyrosinase. The results highlight the importance of protein quality-control systems in determining functional TYR levels.
Mutational Analysis of Copper Binding by Human Tyrosinase
Site-directed mutagenesis was used to examine residues involved in copper binding. Because copper ions are essential to tyrosinase catalysis, mutations disrupting these sites can produce profound loss of enzymatic activity.
Aberrant ER Retention of Tyrosinase in Amelanotic Melanoma
| Multiple authors | Proceedings of the National Academy of Sciences | 1997
Amelanotic melanoma cells retained immature tyrosinase in the ER and degraded it rapidly. The findings show how disrupted TYR processing can contribute to loss of pigmentation in malignant melanocytes.
Analysis of Mutations in the Copper-Binding Region of TYR in OCA1
| W. S. Oetting and R. A. King | Pigment Cell Research | 1992
This research focuses on mutations affecting the copper-binding portion of tyrosinase. Because copper coordination is required for oxidation of tyrosine and DOPA, variants in this region can severely impair melanogenesis.
TYR Gene Regulation and Melanogenesis
TPC2 Regulates Melanosomal pH and Tyrosinase-Dependent Melanin Synthesis
| Multiple authors | Journal of Biological Chemistry | 2024
TPC2 was identified as an important component of signaling that controls melanosomal pH. Because TYR activity is strongly pH dependent, ion-channel regulation can substantially affect pigmentation.
LC3 Regulates Melanogenesis Through MITF and Tyrosinase
| Multiple authors | Scientific Reports | 2016
Manipulation of the autophagy-associated protein LC3 altered MITF, TYR expression, tyrosinase activity, melanosome formation, and cellular melanin content.
From Tyrosine to Melanin: Signaling Pathways Regulating Melanogenesis
| Multiple authors | Postepy Higieny i Medycyny Doswiadczalnej | 2016
This review integrates the cAMP/PKA/CREB/MITF, MAP kinase, PKC, and nitric-oxide signaling pathways that regulate TYR expression and activity during melanogenesis.
IRF4 Controls Pigmentation Through a TYR-Dependent Regulatory Pathway
| Multiple authors | Cell | 2013
A pigmentation-associated regulatory variant in IRF4 affects a network involving TFAP2A and MITF. IRF4 and MITF cooperate to activate TYR expression, connecting noncoding human variation with measurable pigmentation differences.
miR-137 Regulates Pigmentation Through MITF and TYR
| Multiple authors | Journal of Investigative Dermatology | 2012
Overexpression of microRNA-137 in mice reduced MITF and downstream pigmentation genes including TYR, producing lighter coat coloration and demonstrating post-transcriptional regulation of the melanogenic pathway.
The Tyrosinase Enhancer Is Activated by Sox10 and MITF
| Multiple authors | Pigment Cell Research | 2007
A distal TYR regulatory element contains conserved sites responsive to Sox10 and MITF. The study illustrates how melanocyte lineage factors cooperate to maintain cell-specific tyrosinase expression.
MITF Is Required but Not Sufficient for Melanogenic Gene Expression
| Cédric Gaggioli et al. | Pigment Cell Research | 2003
Experimental manipulation of MITF demonstrated its central importance for TYR expression and melanogenesis while showing that additional regulatory components are required for full melanocyte differentiation.
USF-1 Mediates UV-Induced Tyrosinase Expression
| Multiple authors | EMBO Journal | 2001
Ultraviolet radiation activates p38 kinase, which phosphorylates USF-1. Activated USF-1 then contributes to increased TYR promoter activity, providing a molecular connection between UV exposure and tanning.
Tyrosine Concentration Regulates the Melanogenic Response to Alpha-MSH
| D. J. Schwahn et al. | Pigment Cell Research | 2001
Availability of the TYR substrate tyrosine alters melanocyte proliferation and melanogenesis. The work demonstrates that pigmentation depends on both expression of TYR and the biochemical environment in which the enzyme operates.
Up-Regulation of the Tyrosinase Gene by Nitric Oxide
| Multiple authors | Pigment Cell Research | 2000
Nitric oxide, which can be generated following ultraviolet exposure, rapidly increased TYR messenger RNA in human melanocytes, providing another mechanism linking environmental stimuli with melanogenesis.
cAMP-Dependent Protein Kinase and Alpha-MSH-Induced TYR Expression
| Multiple authors | Molecular and Cellular Endocrinology | 1998
Inhibition of protein kinase A substantially reduced alpha-MSH-induced increases in TYR messenger RNA, protein, enzymatic activity, and melanin, confirming the importance of the cAMP-PKA pathway.
Functional Analysis of MITF in Human Tyrosinase Family Genes
| K. Yasumoto et al. | Journal of Biological Chemistry | 1997
This study demonstrates how the transcription factor MITF regulates TYR and related pigmentation genes. MITF is a central regulator of melanocyte differentiation and coordinates expression of multiple components of the melanogenesis pathway.
The Regulation of Tyrosinase Gene Transcription
| Multiple authors | PubMed-indexed review | 1997
This review examines promoter elements and transcription factors governing TYR expression. Regulation of transcription helps explain why tyrosinase production varies with melanocyte differentiation, signaling pathways, and environmental stimuli.
Regulation of Tyrosinase Gene Expression by cAMP in B16 Melanoma Cells
| C. Bertolotto, K. Bille, J. P. Ortonne, and R. Ballotti | Journal of Cell Biology | 1996
Experiments show how cyclic-AMP signaling increases tyrosinase expression in pigment cells. The pathway forms part of the molecular connection between melanocortin signaling, MITF activation, TYR expression, and increased melanin synthesis.
Transcriptional Activation of Melanocyte-Specific Genes by MITF
| Multiple authors | PubMed-indexed molecular biology study | 1996
This study establishes MITF as a transcriptional activator of genes required for melanocyte pigmentation, including TYR. It helped define the regulatory network that controls melanocyte differentiation and melanogenesis.
Melanocyte-Specific Expression of the Human Tyrosinase Promoter
| Multiple authors | PubMed-indexed molecular biology study | 1994
Experiments with the human TYR promoter identify regulatory sequences responsible for preferential expression in melanocytes, helping explain how pigment-cell-specific transcription is established.
MITF as a Regulator of Human Tyrosinase Transcription
| Multiple authors | Journal of Biological Chemistry | 1994
This foundational study demonstrated that microphthalmia-associated transcription factor can activate the human TYR promoter through pigment-cell-specific regulatory sequences.
A Pigment Cell-Specific Enhancer of the Human TYR Gene
| Multiple authors | Journal of Biological Chemistry | 1992
Researchers identified an upstream cis-regulatory element that strongly enhances TYR transcription in pigment-producing cells but not in nonpigmented cells.
Human Pigmentation Variation, Population Genetics, and Evolution
Simultaneous Genotyping of Pigmentation Variants rs1042602, rs1426654, and rs16891982
| Mikiko Soejima and Yoshiro Koda | Human Mutation | 2025
Researchers developed a method for simultaneously examining important pigmentation-associated variants in TYR, SLC24A5, and SLC45A2. These loci are widely used in studies of human pigmentation variation and population history.
Genetics and Evolution of Human Pigmentation
| Multiple authors | PubMed-indexed review | 2025
This recent review integrates molecular genetics, population genomics, natural selection, and evolutionary history to explain global human pigmentation diversity, including the contribution of TYR and other melanogenesis genes.
Pigmentation Variants, TYR, and Vitamin D in a Mexican Population
| Multiple authors | European Journal of Clinical Nutrition | 2024
Variants including TYR rs1042602 and rs1126809 were analyzed for associations with pigmentation, vitamin D concentrations, and vitamin D deficiency in a Mexican cohort.
Analysis of Skin Pigmentation and Genetic Ancestry in Pakistan
| Multiple authors | PubMed-indexed population genetics study | 2021
This population study examines pigmentation measurements, genetic ancestry, and pigmentation-associated loci in Pakistan, illustrating the complex interaction of TYR-related pathways with other genes contributing to normal human skin-color diversity.
Pigmentation Gene Variation and Geographic Environment in Chinese Populations
| Multiple authors | Molecular Genetics and Genomics | 2021
Analysis of several Chinese ethnic groups found geographic differences in frequencies of TYR rs1042602 and rs1126809. Frequencies correlated with latitude, longitude, temperature, and sunshine exposure.
Association Between Brown Eye Color and SNPs in TYR, TYRP1, and SLC24A4
| Multiple authors | PubMed-indexed pigmentation study | 2020
This study examines common genetic variants associated with iris pigmentation. TYR polymorphisms contribute to normal variation in eye color as well as, when severely disrupted, inherited albinism.
Meta-Analysis of Genome-Wide Association Studies on Skin Pigmentation in Admixed Populations
| Multiple authors | PubMed-indexed genome-wide association study | 2019
This meta-analysis evaluates pigmentation loci in genetically admixed populations. TYR appears within a broader network of genes whose common variants contribute quantitatively to differences in human skin pigmentation.
Genome-Wide Association Study in Latin Americans and Convergent Evolution of Lighter Skin
| Multiple authors | Nature Communications | 2019
Genome-wide analysis of Latin American populations identified pigmentation loci and showed that lighter pigmentation evolved through different genetic routes in different populations, illustrating convergent evolution in human pigmentation.
Association of Genetic Variants With Skin Pigmentation in West Maharashtra
| Multiple authors | American Journal of Human Biology | 2016
Researchers studied common pigmentation-associated variants in an Indian population. The findings illustrate how alleles in TYR and other pigmentation genes contribute to continuous variation in skin color.
Direct Evidence for Positive Selection of Pigmentation Genes in Europeans
| Multiple authors | Proceedings of the National Academy of Sciences | 2014
Ancient DNA was used to track pigmentation-associated alleles through time. The analysis found evidence of recent natural selection affecting pigmentation loci including TYR, illustrating the continuing evolution of human coloration after settlement of Europe.
Pigmentation Variants and Self-Assessed Color in Brazilians
| Multiple authors | PLOS ONE | 2014
TYR rs1042602 remained significantly associated with pigmentation categories after controlling for genomic ancestry, demonstrating its contribution within highly admixed Brazilian populations.
Genetic Architecture of Skin and Eye Color in Cape Verde
| Multiple authors | PubMed-indexed population genetics study | 2013
Genetic analysis of the highly admixed Cape Verde population identifies loci affecting skin and eye pigmentation. The study provides insight into how pigmentation alleles act across African and European ancestry backgrounds.
Genetic Analysis of Human Eye Color Using Quantitative Iris Imaging
| Multiple authors | Forensic Science International: Genetics | 2013
Quantitative iris measurements confirmed smaller but measurable effects of TYR rs1393350 on eye color after accounting for the much larger effect of the HERC2/OCA2 region.
Molecular Genetics of Human Pigmentation Diversity
| Multiple authors | PubMed-indexed review | 2009
This review integrates discoveries from Mendelian pigmentation disorders and population genetics. TYR illustrates how the same biochemical pathway can produce both severe pigment loss and normal quantitative variation.
Genome-Wide Association Study of Tanning Phenotype
| Multiple authors | PubMed-indexed genome-wide association study | 2009
Genome-wide analysis identifies genetic factors influencing tanning response to ultraviolet radiation. TYR and other pigmentation genes help determine baseline pigmentation and an individual's response to sun exposure.
Pigmentation Genotypes, Melanin Content, and Tyrosinase Activity in Cultured Human Melanocytes
| Anthony L. Cook et al. | Journal of Investigative Dermatology | 2009
Cultured melanocytes with different pigmentation genotypes were compared for melanin content and TYR activity, helping connect population-genetic associations with functional cellular differences.
Genome-Wide Association Study of Skin Pigmentation in South Asians
| Multiple authors | American Journal of Human Genetics | 2007
Genome-wide analysis of South Asian pigmentation demonstrates that common genetic variants explain part of normal skin-color variation. TYR belongs to the broader melanogenesis network examined in subsequent population studies.
Genetic Determinants of Hair, Eye, and Skin Pigmentation in Europeans
| Multiple authors | Nature Genetics | 2007
Large-scale association analysis identified variants in pigmentation genes that predict normal differences in hair, iris, and skin color among Europeans. TYR variants contribute particularly to eye color and pigmentation phenotypes.
Pigmentation-Related Skin and Eye Phenotypes and Cancer Risk
TYR Polymorphism and Melasma in African Women
| Multiple authors | PubMed-indexed pigmentation study | 2025
A pilot study found an association between the TYR rs1042602 genotype and facial melasma among women of African descent, suggesting that common pigmentation alleles may influence hyperpigmentation disorders.
Genetic Basis of Iris Freckles and Nevi
| Multiple authors | PubMed-indexed ophthalmic genetics study | 2025
More than one thousand individuals of Spanish ancestry were analyzed for iris pigmentation traits. TYR variation was among the genetic factors associated with iris nevi in certain eye-color groups.
Association of TYR SNP rs1042602 With Melanoma Risk and Prognosis
| Arrate Sevilla et al. | Life | 2022
Researchers investigated the common TYR S192Y polymorphism rs1042602 in melanoma. The results support a relationship between inherited pigmentation genetics, melanoma susceptibility, and potentially clinical outcome.
Skin Pigmentation Polymorphisms and Melanoma in Southern Brazil
| Multiple authors | PubMed-indexed melanoma genetics study | 2020
Researchers evaluated pigmentation-associated variants in an admixed Brazilian population and their relationship with melanoma. The study illustrates how inherited pigmentation genetics can influence cancer risk differently across ancestry backgrounds.
TYR and Risk of Actinic Keratosis
| Multiple authors | Journal of Investigative Dermatology | 2015
A European GWAS found TYR rs1393350 associated with actinic keratosis even after adjustment for measured skin color, suggesting TYR-related effects extending beyond visible pigmentation alone.
Increased Melanoma Risk Associated With Pigmentation Genes Including TYR
| Multiple authors | PubMed-indexed cancer genetics study | 2014
Genetic association analysis connects common variants in pigmentation pathways with melanoma susceptibility. TYR can influence melanoma risk both through pigmentation phenotype and potentially through melanocyte-specific biological mechanisms.
Genetic Variants in Pigmentation Genes and Risk of Skin Cancer
| Multiple authors | PubMed-indexed cancer genetics study | 2009
Researchers examined pigmentation-gene polymorphisms in relation to skin-cancer risk. TYR variants contribute to inherited pigmentation phenotypes that can modify ultraviolet sensitivity and susceptibility to melanoma or other skin cancers.
Genome-Wide Association Study Identifies a Melanoma Locus Encompassing TYR
| Multiple authors | Nature Genetics | 2009
A large melanoma GWAS identified a major susceptibility signal at chromosome 11q14-q21 encompassing TYR, linking inherited pigmentation biology with melanoma susceptibility.
TYR, Vitiligo, and Autoimmunity
Genetic Association of TYR rs7129973 With Vitiligo Vulgaris in Mexicans
| M. A. Salinas-Santander et al. | Actas Dermo-Sifiliográficas | 2025
This case-control study evaluates a TYR polymorphism in Mexican patients with vitiligo, adding population-specific evidence to research connecting pigmentation genes with autoimmune destruction of melanocytes.
TYR Polymorphisms and Gene Expression in Vitiligo
| Multiple authors | Advances in Dermatology and Allergology | 2023
TYR rs1393350 and other immune-related polymorphisms were studied in vitiligo patients. Researchers also found altered gene-expression patterns in both lesional and non-lesional skin.
Oxidized Tyrosinase as an Antigenic Stimulus in Vitiligo
| Multiple authors | Journal of Dermatological Science | 2015
Oxidative modification changed TYR structure and increased antibody recognition in vitiligo sera, providing a possible mechanism through which cellular oxidative stress could promote melanocyte autoimmunity.
Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo
| Multiple authors | New England Journal of Medicine | 2010
Genome-wide association analysis identified TYR among loci influencing generalized vitiligo susceptibility. The finding links a melanocyte differentiation antigen involved in normal pigmentation with autoimmune targeting of melanocytes.
Vitiligo Antibodies Are Not Directed to Tyrosinase
| Multiple authors | Archives of Dermatology | 1999
This study challenged earlier conclusions by using several assays and finding little evidence that common vitiligo antibodies specifically recognize functional tyrosinase, illustrating continuing debate over TYR autoimmunity.
Tyrosinase Epitopes Recognized by Autoantibodies in Vitiligo
| Multiple authors | Clinical and Experimental Immunology | 1999
Researchers mapped several regions of the human TYR protein recognized by antibodies from vitiligo patients, including epitopes sharing sequence similarity with other tyrosinase-family proteins.
Cross-Reactive Autoantibodies to TYRP1 and Tyrosinase
| Multiple authors | Clinical and Experimental Immunology | 1999
Some vitiligo sera contained antibodies reacting with TYRP1 as well as TYR and TYRP2, suggesting shared epitopes may generate cross-reactive autoimmune responses against melanogenic enzymes.
Pmel17 Autoantibodies and Concurrent Responses to Tyrosinase
| Multiple authors | Clinical and Experimental Immunology | 1998
Vitiligo patients with antibodies to Pmel17 frequently also showed immune reactivity against tyrosinase and other melanocyte proteins, supporting the concept of broad melanocyte antigen targeting.
Detection of Tyrosinase Autoantibodies Using Recombinant Human TYR
| E. H. Kemp et al. | Journal of Investigative Dermatology | 1997
A radioimmunoassay detected TYR autoantibodies in a subset of vitiligo patients, particularly some individuals who also had autoimmune endocrine disorders.
Autoantibodies to Tyrosinase: The Bridge Between Melanoma and Vitiligo
| Multiple authors | Cancer | 1997
This review explores immune recognition of tyrosinase in vitiligo, melanoma, and melanoma-associated depigmentation and discusses potential implications for antitumor immunity.
Tyrosinase as an Autoantigen in Patients With Vitiligo
| Multiple authors | Clinical and Experimental Immunology | 1996
Researchers detected antibodies reacting with tyrosinase in patients with vitiligo and proposed TYR as one of the melanocyte antigens capable of becoming an autoimmune target.
The Role of Tyrosinase in Autoimmune Vitiligo
| Multiple authors | British Journal of Dermatology | 1994
Sera from many patients with vitiligo and associated endocrine autoimmunity reacted with recombinant human tyrosinase, supporting a possible role for TYR-directed immune responses.
TYR as a Melanoma Antigen and Immunotherapy
High HLA-A2-Tyrosinase Presentation in Melanoma Cells
| Multiple authors | European Journal of Immunology | 2012
Melanoma cells with unstable, improperly processed TYR displayed high levels of TYR-derived HLA-A2 peptide complexes. Protein degradation can therefore increase immune presentation of tyrosinase epitopes.
HLA-B*4002-Restricted Tyrosinase Epitope
| Multiple authors | Cancer Immunology, Immunotherapy | 2008
Melanoma-derived cytotoxic T lymphocytes recognized TYR peptides spanning residues 315–324, adding another HLA-specific target for potential melanoma immunotherapy.
Novel TYR T-Cell Epitopes in Patients Responding to IL-2
| Multiple authors | Cancer Research | 2002
Several HLA-A1-restricted TYR peptides were recognized by circulating T cells from melanoma patients who responded clinically to interleukin-2-based treatment.
A New HLA-A2.1-Restricted Epitope From Tyrosinase
| Multiple authors | Journal of Immunotherapy | 2001
Researchers identified TYR residues 8–17 as an immunogenic HLA-A2.1 peptide capable of generating T cells that recognize tyrosinase-expressing melanoma cells.
Tyrosinase Peptide Vaccine Responses in Melanoma
| Multiple authors | Clinical Cancer Research | 2001
Melanoma patients vaccinated with TYR and gp100 peptides generated detectable cytotoxic T-cell responses, particularly within lymph nodes draining the vaccination site.
HLA-B35-Restricted Tyrosinase Peptide in Human Melanoma
| Multiple authors | International Journal of Cancer | 1999
A nine-amino-acid TYR-derived peptide was recognized by autologous melanoma-specific cytotoxic lymphocytes when presented by common HLA-B35 alleles.
CD4 T Cells Recognize Nonmutated Tyrosinase Peptides
| Multiple authors | Cancer Research | 1998
CD4-positive T cells from a melanoma patient recognized a peptide derived from normal TYR presented by HLA-DR15, showing that tyrosinase can stimulate helper as well as cytotoxic T-cell responses.
HLA-B44-Restricted Tyrosinase Peptide Recognized by Melanoma T Cells
| V. G. Brichard et al. | European Journal of Immunology | 1996
Cytotoxic T lymphocytes recognized a peptide derived from residues 192–200 of human tyrosinase presented by HLA-B44, establishing TYR as a shared melanoma differentiation antigen.
HLA-DR-Restricted Tyrosinase Epitopes in Melanoma
| Multiple authors | Journal of Experimental Medicine | 1996
Melanoma-reactive CD4 T cells were shown to recognize nonmutated TYR-derived epitopes, supporting vaccine strategies capable of recruiting both CD4 and CD8 immune responses.
Two Tyrosinase Nonapeptides Recognized on HLA-A2 Melanoma
| Multiple authors | European Journal of Immunology | 1994
Two distinct TYR-derived peptides, including one originating from the signal sequence, were identified as targets of melanoma-specific HLA-A2-restricted cytotoxic T cells.
Forensic DNA Phenotyping
HIrisPlex-S in a North German Population
| Multiple authors | PubMed-indexed forensic genetics study | 2026
Testing in a North German cohort found particularly strong performance for blue and brown eye prediction while highlighting greater difficulty distinguishing hair and skin-color categories.
Forensic DNA Phenotyping in an Italian Population
| Giulia Fazio et al. | Legal Medicine | 2026
This study analyzes pigmentation markers used to predict eye and hair color in Italians and develops population-specific allele-frequency reference data for forensic interpretation.
HIrisPlex-S Pigmentation Predictions in a Spanish Population
| Multiple authors | Genes | 2024
Researchers evaluated HIrisPlex-S in more than 400 Spanish individuals and documented strong prediction for several pigmentation classes while identifying limitations for intermediate phenotypes.
Prediction of Eye, Hair, and Skin Color in Latin Americans
| Multiple authors | Forensic Science International: Genetics | 2021
More than 6,500 Latin Americans were analyzed to compare pigmentation-prediction models. Results illustrate how genetic ancestry and population diversity influence prediction performance.
Pigmentation of Ancient and Contemporary Native Americans
| Multiple authors | Forensic Science International: Genetics | 2020
Researchers applied HIrisPlex-S and other DNA-prediction systems to ancient genomes and contemporary Native American genetic data to infer probable eye, hair, and skin pigmentation.
Massively Parallel Sequencing Implementation of HIrisPlex-S
| Krystal Breslin et al. | Forensic Science International: Genetics | 2019
Researchers adapted HIrisPlex-S for two major massively parallel sequencing platforms, allowing pigmentation-associated SNPs including TYR markers to be analyzed from forensic DNA samples.
The HIrisPlex-S System for Eye, Hair, and Skin Color Prediction
| Lakshmi Chaitanya et al. | Forensic Science International: Genetics | 2018
HIrisPlex-S combines pigmentation-associated SNPs to predict eye, hair, and skin color from DNA. TYR markers form part of the validated forensic prediction panel.
Collaborative EDNAP Exercise on the IrisPlex System
| Multiple authors | Forensic Science International: Genetics | 2014
Twenty-one forensic laboratories evaluated the reproducibility of IrisPlex. TYR rs1393350 is one of six SNPs incorporated into the standardized eye-color prediction system.
Prediction of Eye Color in the Slovenian Population Using IrisPlex
| Vanja Kastelic et al. | Croatian Medical Journal | 2013
The IrisPlex system was tested in Slovenian individuals using six major pigmentation SNPs, including TYR rs1393350, to estimate probabilities of blue, brown, and intermediate eye color.
SNP Multiplex Prediction of Eye and Hair Color in Slovenia
| Vanja Kastelic and Katja Drobnič | Croatian Medical Journal | 2012
A multiplex containing TYR rs1393350 and variants from OCA2, HERC2, MC1R, SLC45A2, and SLC24A5 was evaluated for predicting eye and hair pigmentation.
Comparative Genetics and Animal TYR Models
A TYR Missense Mutation Explains Acromelanism in Domestic Canaries
| Margarida Guimarães-Moreira et al. | Animal Genetics | 2024
Genome analysis linked the pearl acromelanistic phenotype of domestic canaries to a TYR p.P45H substitution. The finding suggests temperature-sensitive tyrosinase pigmentation can evolve independently in birds as well as mammals.
Generation of Albino Medaka by CRISPR/Cas9 Disruption of tyr
| Multiple authors | Journal of Experimental Zoology Part B | 2018
CRISPR/Cas9 targeting of medaka tyr efficiently produced heritable albino animals, demonstrating TYR's utility as a visible reporter locus for genome-editing experiments.
TYR Mutation Causes Albinism in Asinara White Donkeys
| V. J. Utzeri et al. | Animal Genetics | 2016
The distinctive white donkeys of Asinara Island carry a recessive TYR p.His202Asp mutation affecting the first copper-binding site of the enzyme.
Tyrosinase Nonsense Mutation in Albino American Mink
| R. Anistoroaei et al. | Animal Genetics | 2008
A TYR nonsense mutation truncating most of the protein was strongly associated with albinism in American mink, including loss of the enzyme's catalytic domains.
TYR Exon 4 Deletion in Albino Ferrets
| Multiple authors | Animal Genetics | 2007
Albino ferrets were found to carry a deletion involving exon 4 of TYR. The study demonstrated another mammalian example of recessive albinism caused directly by disruption of the tyrosinase gene.
Albinism in the Domestic Cat Is Associated With a TYR Mutation
| Multiple authors | Animal Genetics | 2006
Albino domestic cats were found to carry a frameshift-producing deletion in TYR. Genetic segregation supported TYR as the classical feline color locus.
TYR Mutations Associated With Siamese and Burmese Cats
| Multiple authors | Animal Genetics | 2005
Distinct missense mutations in feline TYR cause the temperature-sensitive Siamese and Burmese pigmentation patterns. The mutations illustrate how partial TYR activity can generate striking regional color differences.
TYR and TYRP1 Alleles Specify Domestic Cat Coat Colors
| A. Schmidt-Küntzel et al. | Journal of Heredity | 2005
Genetic analysis demonstrated that variants of TYR explain Siamese and Burmese phenotypes while TYRP1 variants account for chocolate and cinnamon coloration.
The Tyr Albino Locus of the Laboratory Mouse
| Friedrich Beermann, Seth J. Orlow, and M. Lynn Lamoreux | Mammalian Genome | 2004
This review describes the extensive series of mouse Tyr alleles ranging from normal pigmentation to complete albinism. These strains provide valuable models for studying TYR function, visual development, and pigmentation biology.
A Tyrosinase Frameshift Mutation Causes Albinism in Cattle
| Sheila M. Schmutz et al. | Mammalian Genome | 2004
Albino Braunvieh cattle were homozygous for a TYR frameshift mutation that creates a premature stop codon, providing a large-animal model of loss-of-function tyrosinase deficiency.
The Tyrosinase Gene in Gorillas and the Albinism of Snowflake
| Multiple authors | Pigment Cell Research | 2000
Genetic analysis of Snowflake, the famous albino western lowland gorilla, examined TYR as a candidate cause of albinism and provides a comparative perspective on conservation of pigmentation genes among primates.
Oculocutaneous Albinism in Medaka Caused by TYR Deletion
| A. Koga et al. | Pigment Cell Research | 1999
A deletion spanning an intron-exon boundary of the medaka tyrosinase gene causes complete albinism, providing a useful fish model for genetic studies of pigmentation.
Transgenic TYR Expression Rescues Albinism in Medaka
| Multiple authors | Gene | 1998
Introduction of normal medaka tyrosinase genomic DNA or TYR cDNA restored pigmentation in albino embryos, experimentally demonstrating that the medaka i locus corresponds to tyrosinase.
Transposable Element Insertions Cause TYR-Related Albinism in Medaka
| Multiple authors | Pigment Cell Research | 1997
Distinct transposable-element insertions disrupting the medaka tyrosinase gene caused complete or partial albinism and provided an unusual model of mobile-element-induced pigmentation mutations.
Experimental Therapy, Gene Transfer, and Genome Editing
Tyrosinase-Driven Intracellular Polymerization for Melanoma Photodynamic Therapy
| Mian Tang et al. | Advanced Science | 2026
A TYR-responsive porphyrin system exploits elevated tyrosinase activity in melanoma cells to trigger intracellular polymerization and enhance photodynamic therapy and immunogenic tumor-cell death.
Retinal Pigment Epithelium-Targeting Gene Therapy Corrects OCA1
| Multiple authors | PubMed-indexed experimental study | 2025
An experimental AAV-based therapy delivered functional human TYR to retinal pigment epithelium in animal models of OCA1. Treatment restored tyrosinase expression and melanin production, demonstrating a potential genetic treatment strategy for albinism-associated ocular abnormalities.
CRISPR-Engineered Human iPSC Line With TYR S192Y and R402Q
| Multiple authors | Stem Cell Research | 2022
CRISPR/Cas9 was used to generate human induced pluripotent stem cells homozygous for the common TYR S192Y and R402Q alleles, creating a controlled system for investigating their biological effects.
Nitisinone Improves Pigmentation in a Mouse Model of OCA1
| Multiple authors | Journal of Clinical Investigation | 2011
Increasing circulating tyrosine with nitisinone enhanced pigmentation in a temperature-sensitive OCA1B mouse model but not in animals completely lacking functional TYR, suggesting therapy may depend on residual enzyme activity.
AAV-Mediated TYR Gene Transfer Restores Melanogenesis
| Multiple authors | Human Molecular Genetics | 2009
Delivery of human TYR with an adeno-associated virus restored ocular melanogenesis in an OCA1 mouse model and improved retinal function, providing early proof of concept for TYR gene replacement.
Foundational TYR Gene Mapping, Cloning, and Genomic Organization
Organization and Nucleotide Sequences of the Human TYR Gene
| Multiple authors | Genomics | 1991
This foundational study describes the genomic organization and nucleotide sequence of human TYR. Defining the exon-intron structure made systematic mutation screening and molecular diagnosis of OCA1 possible.
Nucleotide Sequence of a Putative Human Tyrosinase Pseudogene
| A. Takeda et al. | Tohoku Journal of Experimental Medicine | 1991
Researchers characterized a DNA sequence related to TYR that was interpreted as a possible pseudogene. Such homologous sequences were important to recognize because they could complicate early mutation analysis and amplification of the authentic TYR locus.
Molecular Analysis of DNA Segments Cross-Hybridizable to the Human Tyrosinase Gene
| Multiple authors | PubMed-indexed molecular genetics study | 1989
Researchers investigated genomic sequences sharing similarity with TYR. Characterizing these related sequences was important for distinguishing the functional tyrosinase locus from homologous genomic DNA during early gene mapping and mutation studies.
Human TYR Mapped to Chromosome 11q14-q21
| Multiple authors | PubMed-indexed gene-mapping study | 1988
Cytogenetic and molecular mapping placed the human tyrosinase locus on chromosome 11, providing an essential foundation for linking TYR with inherited human pigmentation disorders.
Cloning and Characterization of a Human Tyrosinase cDNA
| Multiple authors | PubMed-indexed molecular biology study | 1988
Cloning of human tyrosinase complementary DNA provided the sequence needed to characterize the protein, compare it with tyrosinases from other species, and begin identifying mutations responsible for human albinism.
Molecular Basis for the Heterogeneity of Human Tyrosinase
| Multiple authors | PubMed-indexed biochemical study | 1988
Early molecular work investigated the different forms and processing states of human tyrosinase, contributing to understanding of how synthesis, glycosylation, maturation, and intracellular transport influence enzymatic activity.
